Neuroglobin and Prolactin As Potential Biomarkers for Differentiating Epileptic versus Nonepileptic Paroxysmal Disorders in Children

Abstract

At least 20% of patients referred to pediatric epilepsy centers with the suspicion of epileptic seizures actually have other conditions. Neuroglobin is a new globin member which is highly expressed in the central and peripheral nervous systems. In this article, we aimed to evaluate usefulness of neuroglobin to differentiate between epilepsy and other conditions that mimic epilepsy. Our study was conducted on 90 children divided into three groups: 30 patients with epileptic seizures, 35 children with nonepileptic paroxysmal disorder, and 25 apparently healthy, age and sex-matched children as a normal control. Complete blood count, blood chemistries including random blood glucose, calcium, sodium, in addition to serum prolactin, and neuroglobin were performed for all children. This study showed a significant increase of both serum neuroglobin and prolactin levels in epileptic group compared with nonepileptic paroxysmal disorder and control groups (p < 0.01). Serum neuroglobin showed 95% sensitivity and 95.7% specificity in the diagnosis of generalized seizures. Serum neuroglobin may be a promising novel marker to differentiate epileptic versus nonepileptic disorders in children in the emergency setting, when history and clinical presentation are equivocal.

Keywords

neuroglobin - prolactin - nonepileptic disorders

Ethical Approval

Informed written consents were obtained from the patient's legal guardians before enrollment in our study, after the Ethical Committee of Faculty of Medicine, Minia University, Egypt approved the study (No 152:4/2018).

Publikationsverlauf

Eingereicht: 14. Februar 2020

Angenommen: 11. April 2021

Artikel online veröffentlicht:
19. Juni 2020

• References

• 1 Hamiwka LD, Singh N, Niosi J, Wirrell EC. Diagnostic inaccuracy in children referred with “first seizure”: role for a first seizure clinic. Epilepsia 2007; 48 (06) 1062-1066
• 2 Wahab A. Difficulties in treatment and management of epilepsy and challenges in new drug development. Pharmaceuticals (Basel) 2010; 3 (07) 2090-2110
• 3 Tatlı B, Güler S. Non epileptic paroxysmal events in childhood. Turk Pediatri Ars 2017; 52 (02) 59-65
• 4 Chaurasiya OS, Gupta P, Kaushik A, Yadav R. Usefulness of serum prolactin in differentiating epileptic and pseudoseizures in children. People's J Sci Res 2013; 6 (01) 29-32
• 5 Burmester T, Weich B, Reinhardt S, Hankeln T. A vertebrate globin expressed in the brain. Nature 2000; 407 (6803): 520-523
• 6 Qiu XY, Chen XQ. Neuroglobin—recent developments. Biomol Concepts 2014; 5 (03) 195-208
• 7 Alekseeva OS, Grigor'ev IP, Korzhevskii DE. Neuroglobin, an oxygen-binding protein in the mammalian nervous system (localization and putative functions). J Evol Biochem Physiol 2017; 53: 249-258
• 8 Baez E, Echeverria V, Cabezas R, Ávila-Rodriguez M, Garcia-Segura LM, Barreto GE. Protection by neuroglobin expression in brain pathologies. Front Neurol 2016; 7: 146
• 9 Yaxian D, Baoqin G, Jianguo Z. Expression of neuroglobin in the resected brain tissues of intractable epileptic patients. Chin J Pract Pediatr 2005; 9 (01) 10
• 10 Pesce A, Dewilde S, Nardini M. et al. Human brain neuroglobin structure reveals a distinct mode of controlling oxygen affinity. Structure 2003; 11 (09) 1087-1095
• 11 DellaValle B, Hempel C, Kurtzhals JA, Penkowa M. In vivo expression of neuroglobin in reactive astrocytes during neuropathology in murine models of traumatic brain injury, cerebral malaria, and autoimmune encephalitis. Glia 2010; 58 (10) 1220-1227
• 12 Fisher RS, Cross JH, French JA. et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia 2017; 58 (04) 531-542
• 13 Meir JU, Ponganis PJ. High-affinity hemoglobin and blood oxygen saturation in diving emperor penguins. J Exp Biol 2009; 212 (Pt 20): 3330-333
• 14 Mounir MS, Abdel-Mohsen A, Saedii AA, Hassan MH. Neuroglobin as a novel biomarker in childhood seizures. Neuropsychiatry (London) 2019; 9 (02) 749-751
• 15 Biyani G, Kumar S, Chatterjee K, Sen S, Mandal PK, Mukherjee M. Leukocyte count and C reactive protein as diagnostic factors in febrile convulsion. Asian J Med Sci 2017; 8: 56-58
• 16 Mahmoud AT, El Deghady AA. Serum prolactin and creatine kinase levels in epileptic and non epileptic seizures. Alex J Pediatr 2005; 19: 217-222
• 17 Banerjee S, Paul P, Talib VJ. Serum prolactin in seizure disorders. Indian Pediatr 2004; 41 (08) 827-831
• 18 Shukla G, Bhatia M, Vivekanandhan S. et al. Serum prolactin levels for differentiation of nonepileptic versus true seizures: limited utility. Epilepsy Behav 2004; 5 (04) 517-521
• 19 Fisher RS. Serum prolactin in seizure diagnosis: glass half-full or half-empty?. Neurol Clin Pract 2016; 6 (02) 100-101